Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis

ACR Open Rheumatology(2021)10.1002/acr2.11366Source: DataRank Database

Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis is a research paper published in ACR Open Rheumatology (2021). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)OA: goldTopics (14)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Roscoe L. Warner,Robert Lew ORCID,Gunnar Tómasson ORCID,Ulrich Specks ORCID,John H. Stone ORCID

Live enrichment

PubMed:34792864 PMC:PMC8843765

Immune Tolerance Network

Grant: N01 AI15416

National Center for Research Resources

Grant: U54 RR019497

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: P60 AR047785

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: RC1 AR058303

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: U54 AR057319

NIAID NIH HHS

Grant: N01 AI015416

National Institutes of Health

Grant: 3UL1RR025005-03S2

Institute for Clinical and Translational Research (UL1)

National Institutes of Health

Grant: 1K24AR049185-01

Translational Research in Systemic Vasculitis

National Institutes of Health

Grant: 5U54RR019497-04

Vasculitis Clinical Research Network (VCRN)

National Institutes of Health

Grant: 1RC1AR058303-01

IDENTIFICATION AND VALIDATION OF BIOMARKERS FOR VASCULITIS

National Institutes of Health

Grant: 5U54AR057319-14

Vasculitis Clinical Research Consortium (VCRC)

National Institutes of Health

Grant: 5K23AR052820-02

Development of an ANCA-Vasculitis Index of Damage (AVID)

National Institutes of Health

Grant: 2M01RR000533-30

IMPACT OF PRIMARY CARE ON SUBSTANCE ABUSING PATIENTS IN DETOXIFICATION UNIT

National Institutes of Health

Grant: N01AI015416-003

IMMUNE TOLERANCE NETWORK-266015416

National Institutes of Health

Grant: 3P60AR047785-10S1

NIAMS Multidisciplinary Clinical Research Center

National Institutes of Health

Grant: 5K24AR002224-04

Studies in Scleroderma and Cystic Fibrosis Osteoporosis

goldLicense: cc-by-nc

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr2.11366

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11366

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/acr2.11366

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11366

repositoryhttps://hdl.handle.net/2027.42/171816

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIESREMISSIONDiseases of the musculoskeletal systemOriginal ArticlesRELAPSEC-REACTIVE PROTEINWEGENERS-GRANULOMATOSISRheumatologyRC925-935Health SciencesINJURYFOLLOW-UP

Sustainable Development Goals

SDG 3: 3. Good health